Genetic Technologies (ASX:GTG) — Material Events
ASX:GTG · 4 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Genetic Technologies Emerges from Administration with New Strategy and LeadershipHigh
Genetic Technologies reports increased losses, enters voluntary administration, completes recapitalisation and business sales
20 Aug 2025
·Half Year Report
·Unexpected
·85
Genetic Technologies Sells geneType, Eyes Recapitalisation After AdministrationHigh
Genetic Technologies enters voluntary administration, sells geneType business, and pursues recapitalisation
20 Aug 2025
·Appendix 4C and Quarterly Activities Report
·Unexpected
·85
Genetic Technologies Advances DOCA Amid GeneType Sale and Cash SqueezeMedium
Genetic Technologies in Voluntary Administration, Sells geneType Business, Reports $0.27M Cash at Quarter End
30 Mar 2026
·Appendix 4C and Quarterly Activities Report
·75
No articles in this tier for the last 12 months.
Market Mentions
1
- appeared in market wrap coverage
These are market wrap articles where Genetic Technologies (ASX:GTG) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 14 (30 Mar -> 3 Apr) 2026
4 Apr 2026